Hologic (HOLX) Tops Q3 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Canaccord Genuity Raises Price Target on Hologic (HOLX) Following 3Q Beat and FY15 Guidance Raise
July 30, 2015 10:49 AM EDTCanaccord Genuity reiterated a Buy rating on Hologic (NASDAQ: HOLX), and raised the price target to $45.00 (from $40.00), following FQ3 results. Adjusted EPS of $0.43 beat the Street's $0.39 estimate. Revenues of $693.9M beat consensus estimates of $654M. HOLX raised FY'15 rev guidance by $82M at the midpoint to $2,687-2,697M, from $2,600-2,620M, and... More
